"First they ignore you, then they laugh at you, then they fight you, then you win."
- Mahatma Gandhi
 
Top News arrow Safety Issues
Drug Safety Issues
Public Testimonies at FDA-SSRI-Suicidality Hearings, Dec. 13, 2006 Print E-mail
Thursday, 21 December 2006

Only if one assumes that the FDA sees the drug industry as its client can some sense be made of December 13th meeting of the FDA’s Psychopharmacologic Drugs Advisory Committee in Silver Springs, Maryland.

Read more...
 
Lilly Marketing Zyprexa Challenged by Stat AGs--NYT_Antipsychotics: Off-label Use Print E-mail
Tuesday, 19 December 2006
State Attorney Generals are investigating  the off-label marketing of Zyprexa--which, if documented is a federal crime.
Read more...
 
Documents Show Eli Lilly Lied about Zyprexa Print E-mail
Tuesday, 19 December 2006
The New York Times is calling for congressional hearings after the revelations that Eli LillyDocumented evidence reveal that Eli Lilly glossed over the debilitating hazards of Zyprexa--and aggressively marketed it to primary care physicians.
Read more...
 
Eli Lilly Lies About Zyprexa_NYT Editorial Calls for CongressionalHearings Print E-mail
Monday, 18 December 2006
The New York Times calls for congressional hearings into marketing of Zyprexa.
Read more...
 
AHRQ No Evidence to Support Off-Label Uses of Atypical Antipsychotics Print E-mail
Monday, 18 December 2006
"Most off-label use occurs without scientific support."
Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Results 82 - 90 of 153
(C) 2012 Alliance for Human Research Protection
CMS installation and website development by Anne Krauss

General Terms & Disclaimer:

This site is not a monologue of truth. It is a catalyst for public debate about medical research conduct. The reader is urged to confront officials to clarify issues mentioned herein. This site is designed strictly to provide information for critical, literary, academic an public usage. A qualified and trustworthy medical professional must be consulted regarding medical issues, treatments, diagnoses, etc.

Please read the General Terms and Conditions of this agreement entirely and carefully before accessing this web site. By accessing the site, you agree to be bound by the terms and conditions listed herein. [continue]